基因组向三重组形成的寡核酸和核酸的开发和治疗应用的最新进展
1Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyomachi, Nagasaki 852-8521, Japan.
Pharmaceutics
|October 28, 2023
概括
三重形成的寡核酸 (TFO) 和核酸 (PNA) 为遗传疾病提供了新的治疗策略. 这些基因组向工具提供永久的基因编辑,可能会彻底改变药物开发.
科学领域:
- 分子生物学分子生物学
- 药物输送系统 药物输送系统
- 遗传学 遗传学 是一个
背景情况:
- 人工核酸和药物输送系统的进步使新的治疗性寡核酸工程成为可能.
- 反感性寡核酸 (ASOs) 和小干扰性核酸 (siRNAs) 是已确立的寡核酸疗法.
- 目前的基因编辑工具面临着诸如非目标效应和细胞毒性等挑战.
研究的目的:
- 审查三倍体形成的寡核酸 (TFO) 和核酸 (PNA) 技术的进展.
- 突出其作为疾病治疗的共生基因组向工具的潜力.
- 讨论它们与现有的反感性方法相比的优势.
主要方法:
- 对TFO和PNA技术的当前文献的审查.
- 对基因组向的TFO和PNA机制的分析.
- 将TFO/PNA策略与基于核酶的基因编辑方法进行比较 (例如,CRISPR-Cas9).
主要成果:
- TFOs和PNAs可以被设计成共生基因组向工具.
- 这些药物向基因组DNA,比向mRNA的反感药具有优势.
- 通过TFO/PNA进行基因组编辑可以诱导病理基因的永久变化.
结论:
- TFO和PNA技术代表了寡核酸药物开发中的范式转变.
- 它们为开发对遗传疾病的永久治疗提供了一个有希望的途径.
- 进一步开发TFO和PNA技术对于体内治疗应用至关重要.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Microorganisms in Medicine and Therapeutics
35
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
35


